找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

(版塊ONCOLOGY(腫瘤學(xué))版塊期刊總數(shù):80)
新窗
投票 ESCI期刊Rare Tumors 2024/2025影響因子:0.92 (RARE TUMORS) (2036-3605). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:438; 2023 JIF:0.92; JIFRank: 293/322 ; Rank-JIF: 293; Number-of-JIF:322; 5 Year JIF:1.113; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.9; Immediacy Index:0.2; Immediacy Index-dealt:0.292; 2023 JCI:0.18; JCI Rank: 290/322 ; Total Articles:15; JCI Quartile:Q4; JCI Percentile:10.09; Eigenfactor:0; Normalized Eigenfactor:2.314; Article Influence Score:1.015; JIF Percentile:9.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:25; % of Articles in Citable items:0.6; Cited Half-Life:8.6; Citing Half-Life:8.1; % of OA Gold:0.9737; Publisher name:IOP PUBLISHING LTD; Publisher address:TEMPLE CIRCUS, TEMPLE WAY, BRISTOL, ENGLAND, BS
投票 ESCI期刊NAR Cancer 2024/2025影響因子:3.441 (NAR CANCER) (2632-8674). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:617; 2023 JIF:3.441; JIFRank: 110/322 ; Rank-JIF: 110; Number-of-JIF:322; 5 Year JIF:4.176; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:1; Immediacy Index-dealt:1.186; 2023 JCI:0.72; JCI Rank: 139/322 ; Total Articles:53; JCI Quartile:Q2; JCI Percentile:56.99; Eigenfactor:0.002; Normalized Eigenfactor:0.413; Article Influence Score:1.7; JIF Percentile:66; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:60; % of Articles in Citable items:0.8833; Cited Half-Life:2.6; Citing Half-Life:7.6; % of OA Gold:0.9551; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Onkourologiya 2024/2025影響因子:0.163 (ONKOUROLOGIYA) (1726-9776). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:62; 2023 JIF:0.163; JIFRank: 318/322 ; Rank-JIF: 318; Number-of-JIF:322; 5 Year JIF:0.182; 5 Year JIF Quartile:Q4; JIF Without Self Cites:<0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.064; 2023 JCI:0.02; JCI Rank: 319/322 ; Total Articles:55; JCI Quartile:Q4; JCI Percentile:1.09; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.013; JIF Percentile:1.4; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:67; % of Articles in Citable items:0.8209; Cited Half-Life:NULL; Citing Half-Life:6; % of OA Gold:0.9471; Publisher name:ASME; Publisher address:TWO PARK AVE, NEW YORK, USA, NY, 10016-5990;
投票 ESCI期刊Indian Journal of Medical and Paediatric Oncology 2024/2025影響因子:0.366 (INDIAN J MED PAEDIAT) (0971-5851). (ONCOLO  ...234
Total Citations:779; 2023 JIF:0.366; JIFRank: 309/322 ; Rank-JIF: 309; Number-of-JIF:322; 5 Year JIF:0.331; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.129; 2023 JCI:0.04; JCI Rank: 315/322 ; Total Articles:38; JCI Quartile:Q4; JCI Percentile:2.33; Eigenfactor:0; Normalized Eigenfactor:0.075; Article Influence Score:0.075; JIF Percentile:4.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:122; % of Articles in Citable items:0.3115; Cited Half-Life:7.7; Citing Half-Life:8.2; % of OA Gold:0.9931; Publisher name:ACADEMIC PRESS INC ELSEVIER SCIENCE; Publisher address:525 B ST, STE 1900, SAN DI
投票 ESCI期刊Indian Journal of Surgical Oncology 2024/2025影響因子:0.669 (INDIA J SURG ONCOL) (0975-7651). (ONCOLOGY)(腫瘤學(xué))Emerging  ...234
Total Citations:999; 2023 JIF:0.669; JIFRank: 299/322 ; Rank-JIF: 299; Number-of-JIF:322; 5 Year JIF:0.767; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.185; 2023 JCI:0.11; JCI Rank: 302/322 ; Total Articles:125; JCI Quartile:Q4; JCI Percentile:6.37; Eigenfactor:0.001; Normalized Eigenfactor:0.298; Article Influence Score:0.188; JIF Percentile:7.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:159; % of Articles in Citable items:0.7862; Cited Half-Life:4.8; Citing Half-Life:10.2; % of OA Gold:0.0327; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Pleura and Peritoneum 2024/2025影響因子:1.445 (PLEURA PERITONEUM) (2364-7671). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citati  ...234
Total Citations:338; 2023 JIF:1.445; JIFRank: 263/322 ; Rank-JIF: 263; Number-of-JIF:322; 5 Year JIF:2.194; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.2; Immediacy Index:0.3; Immediacy Index-dealt:0.331; 2023 JCI:0.51; JCI Rank: 203/322 ; Total Articles:16; JCI Quartile:Q3; JCI Percentile:38.1; Eigenfactor:0; Normalized Eigenfactor:0.074; Article Influence Score:0.428; JIF Percentile:43.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:20; % of Articles in Citable items:0.8; Cited Half-Life:5.3; Citing Half-Life:6.5; % of OA Gold:0.9531; Publisher name:SCIENDO; Publisher address:BOGUMILA ZUGA 32A, WARSAW, Poland, MAZOVIA, 01-811;
投票 ESCI期刊Gaceta Mexicana de Oncologia 2024/2025影響因子:0.074 (GAC MEX ONCOL) (1665-9201). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cit  ...234
Total Citations:42; 2023 JIF:0.074; JIFRank: 322/322 ; Rank-JIF: 322; Number-of-JIF:322; 5 Year JIF:0.136; 5 Year JIF Quartile:Q4; JIF Without Self Cites:<0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.057; 2023 JCI:0.01; JCI Rank: 322/322 ; Total Articles:37; JCI Quartile:Q4; JCI Percentile:0.16; Eigenfactor:0; Normalized Eigenfactor:0.003; Article Influence Score:0.008; JIF Percentile:0.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.8222; Cited Half-Life:NULL; Citing Half-Life:8.6; % of OA Gold:0.9793; Publisher name:VERLAG KIRCHHEIM; Publisher address:POSTFACH 25 24, MAINZ, GERMANY, 55015;
投票 ESCI期刊Case Reports in Oncology 2024/2025影響因子:0.701 (CASE REP ONCOL) (1662-6575). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citati  ...234
Total Citations:1354; 2023 JIF:0.701; JIFRank: 297/322 ; Rank-JIF: 297; Number-of-JIF:322; 5 Year JIF:0.829; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.6; Immediacy Index-dealt:0.691; 2023 JCI:0.16; JCI Rank: 297/322 ; Total Articles:13; JCI Quartile:Q4; JCI Percentile:7.92; Eigenfactor:0.002; Normalized Eigenfactor:0.414; Article Influence Score:0.233; JIF Percentile:7.9; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:14; % of Articles in Citable items:0.9286; Cited Half-Life:4.7; Citing Half-Life:8.8; % of OA Gold:0.9979; Publisher name:KOREAN BIOCHIP SOCIETY-KBCS; Publisher address:KOREA SCI & TECHNOL CENT, #310
投票 ESCI期刊Oncology Reviews 2024/2025影響因子:3.199 (ONCOL REV) (1970-5557). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:663; 2023 JIF:3.199; JIFRank: 136/322 ; Rank-JIF: 136; Number-of-JIF:322; 5 Year JIF:3.456; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.1; Immediacy Index:0.2; Immediacy Index-dealt:0.255; 2023 JCI:0.45; JCI Rank: 225/322 ; Total Articles:1; JCI Quartile:Q3; JCI Percentile:30.28; Eigenfactor:0.001; Normalized Eigenfactor:0.117; Article Influence Score:0.772; JIF Percentile:57.9; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:10; % of Articles in Citable items:0.1; Cited Half-Life:6.3; Citing Half-Life:8.8; % of OA Gold:1; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Radiation Oncology Journal 2024/2025影響因子:1.819 (RADIAT ONCOL J) (2234-3156). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cita  ...234
Total Citations:722; 2023 JIF:1.819; JIFRank: 241/322 ; Rank-JIF: 241; Number-of-JIF:322; 5 Year JIF:2.131; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.3; Immediacy Index-dealt:0.349; 2023 JCI:0.38; JCI Rank: 249/322 ; Total Articles:27; JCI Quartile:Q4; JCI Percentile:22.83; Eigenfactor:0.001; Normalized Eigenfactor:0.197; Article Influence Score:0.597; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:32; % of Articles in Citable items:0.8438; Cited Half-Life:5.7; Citing Half-Life:6.9; % of OA Gold:0.9703; Publisher name:OXFORD UNIV PRESS INC; Publisher address:JOURNALS DEPT, 2001 EVANS RD, CARY,
投票 ESCI期刊Case Reports in Oncological Medicine 2024/2025影響因子:0.618 (CASE REP ONCOL MED) (2090-6706). (ONCOLOGY)(腫瘤學(xué))Emergin  ...234
Total Citations:492; 2023 JIF:0.618; JIFRank: 299/322 ; Rank-JIF: 299; Number-of-JIF:322; 5 Year JIF:0.898; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.126; 2023 JCI:0.15; JCI Rank: 298/322 ; Total Articles:8; JCI Quartile:Q4; JCI Percentile:7.61; Eigenfactor:0; Normalized Eigenfactor:0.088; Article Influence Score:0.185; JIF Percentile:7.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:10; % of Articles in Citable items:0.8; Cited Half-Life:7.1; Citing Half-Life:7.6; % of OA Gold:0.9796; Publisher name:KOREAN BIOCHIP SOCIETY-KBCS; Publisher address:KOREA SCI & TECHNOL CENT, #310, 635-4,
投票 ESCI期刊Hepatic Oncology 2024/2025影響因子:1.241 (HEPAT ONCOL) (2045-0923). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:263; 2023 JIF:1.241; JIFRank: 273/322 ; Rank-JIF: 273; Number-of-JIF:322; 5 Year JIF:3.293; 5 Year JIF Quartile:Q2; JIF Without Self Cites:1.2; Immediacy Index:<0.1; Immediacy Index-dealt:0.077; 2023 JCI:0.53; JCI Rank: 199/322 ; Total Articles:6; JCI Quartile:Q3; JCI Percentile:38.35; Eigenfactor:0; Normalized Eigenfactor:0.049; Article Influence Score:0.744; JIF Percentile:15.4; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:6; % of Articles in Citable items:1; Cited Half-Life:6.7; Citing Half-Life:4.9; % of OA Gold:0.9333; Publisher name:AMER ASSOC ADVANCEMENT SCIENCE; Publisher address:1200 NEW YORK AVE, NW, WASHINGTON, U
投票 ESCI期刊Middle East Journal of Cancer 2024/2025影響因子:0.478 (MIDDLE EAST J CANCER) (2008-6709). (ONCOLOGY)(腫瘤學(xué))Emerging Sou  ...234
Total Citations:201; 2023 JIF:0.478; JIFRank: 304/322 ; Rank-JIF: 304; Number-of-JIF:322; 5 Year JIF:0.581; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.1; Immediacy Index-dealt:0.131; 2023 JCI:0.09; JCI Rank: 307/322 ; Total Articles:58; JCI Quartile:Q4; JCI Percentile:4.81; Eigenfactor:0; Normalized Eigenfactor:0.066; Article Influence Score:0.116; JIF Percentile:5.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:64; % of Articles in Citable items:0.9063; Cited Half-Life:4.2; Citing Half-Life:8.9; % of OA Gold:0; Publisher name:SPRINGERNATURE; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 ESCI期刊Advances in Radiation Oncology 2024/2025影響因子:2.234 (ADV RADIAT ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cit  ...234
Total Citations:2224; 2023 JIF:2.234; JIFRank: 209/322 ; Rank-JIF: 209; Number-of-JIF:322; 5 Year JIF:2.433; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.7; Immediacy Index-dealt:0.722; 2023 JCI:0.63; JCI Rank: 169/322 ; Total Articles:135; JCI Quartile:Q2; JCI Percentile:51.72; Eigenfactor:0.005; Normalized Eigenfactor:1.037; Article Influence Score:0.748; JIF Percentile:55.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:144; % of Articles in Citable items:0.9375; Cited Half-Life:3.3; Citing Half-Life:7.3; % of OA Gold:0.8154; Publisher name:SCIENDO; Publisher address:BOGUMILA ZUGA 32A, WARSAW, Poland, MAZOVIA, 01
投票 ESCI期刊Lung Cancer-Targets and Therapy 2024/2025影響因子:5.163 (LUNG CANCER-TARGETS) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources  ...234
Total Citations:429; 2023 JIF:5.163; JIFRank: 65/322 ; Rank-JIF: 65; Number-of-JIF:322; 5 Year JIF:3.891; 5 Year JIF Quartile:Q2; JIF Without Self Cites:5.1; Immediacy Index:2; Immediacy Index-dealt:2.155; 2023 JCI:0.6; JCI Rank: 177/322 ; Total Articles:5; JCI Quartile:Q3; JCI Percentile:45.19; Eigenfactor:0; Normalized Eigenfactor:0.102; Article Influence Score:0.926; JIF Percentile:80; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:7; % of Articles in Citable items:0.7143; Cited Half-Life:5.4; Citing Half-Life:4.9; % of OA Gold:0.8889; Publisher name:TURKISH SOC THERMAL SCIENCES TECHNOLOGY; Publisher address:TIBTD MAKINA MUHENDISLIGI BOLU
投票 ESCI期刊Memo-Magazine of European Medical Oncology 2024/2025影響因子:0.405 (MEMO-MAG EUR MED ONC) (1865-5041). (ONCOLOGY)(腫瘤學(xué)  ...234
Total Citations:239; 2023 JIF:0.405; JIFRank: 304/322 ; Rank-JIF: 304; Number-of-JIF:322; 5 Year JIF:0.442; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.2; Immediacy Index-dealt:0.245; 2023 JCI:0.1; JCI Rank: 303/322 ; Total Articles:29; JCI Quartile:Q4; JCI Percentile:6.06; Eigenfactor:0; Normalized Eigenfactor:0.068; Article Influence Score:0.092; JIF Percentile:5.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:77; % of Articles in Citable items:0.3766; Cited Half-Life:4.2; Citing Half-Life:3.1; % of OA Gold:0.4587; Publisher name:UNIV ILLINOIS PRESS; Publisher address:1325 S OAK ST, MC-566, CHAMPAIGN, Usa, IL, 6
投票 ESCI期刊Colorectal Cancer 2024/2025影響因子:2.715 (COLORECTAL CANCER) (1758-194X). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation I  ...234
Total Citations:118; 2023 JIF:2.715; JIFRank: 163/322 ; Rank-JIF: 163; Number-of-JIF:322; 5 Year JIF:2.444; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.7; Immediacy Index:1; Immediacy Index-dealt:1.140; 2023 JCI:0.23; JCI Rank: 285/322 ; Total Articles:3; JCI Quartile:Q4; JCI Percentile:11.65; Eigenfactor:0; Normalized Eigenfactor:0.037; Article Influence Score:0.757; JIF Percentile:49.5; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:4; % of Articles in Citable items:0.75; Cited Half-Life:5.2; Citing Half-Life:5.8; % of OA Gold:0.7143; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Eurasian Journal of Medicine and Oncology 2024/2025影響因子:0.831 (EURASIAN J MED ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerg  ...234
Total Citations:211; 2023 JIF:0.831; JIFRank: 296/322 ; Rank-JIF: 296; Number-of-JIF:322; 5 Year JIF:0.826; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.1; Immediacy Index-dealt:0.187; 2023 JCI:0.36; JCI Rank: 255/322 ; Total Articles:35; JCI Quartile:Q4; JCI Percentile:20.96; Eigenfactor:0; Normalized Eigenfactor:0.062; Article Influence Score:0.147; JIF Percentile:8.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.7778; Cited Half-Life:3.3; Citing Half-Life:7; % of OA Gold:0.9248; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United State
投票 ESCI期刊Rehabilitation Oncology 2024/2025影響因子:1.166 (REHABIL ONCOL) (2168-3808). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation  ...234
Total Citations:222; 2023 JIF:1.166; JIFRank: 287/322 ; Rank-JIF: 287; Number-of-JIF:322; 5 Year JIF:1.187; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.9; Immediacy Index:0.3; Immediacy Index-dealt:0.371; 2023 JCI:0.17; JCI Rank: 294/322 ; Total Articles:10; JCI Quartile:Q4; JCI Percentile:8.85; Eigenfactor:0; Normalized Eigenfactor:0.065; Article Influence Score:0.277; JIF Percentile:11; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:19; % of Articles in Citable items:0.5263; Cited Half-Life:4.9; Citing Half-Life:7.3; % of OA Gold:0.9867; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON
投票 ESCI期刊International Journal of Cancer Management 2024/2025影響因子:0.423 (INT J CANCER MANAG) (2538-4422). (ONCOLOGY)(腫瘤學(xué))E  ...234
Total Citations:290; 2023 JIF:0.423; JIFRank: 304/322 ; Rank-JIF: 304; Number-of-JIF:322; 5 Year JIF:0.525; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.1; Immediacy Index-dealt:0.129; 2023 JCI:0.1; JCI Rank: 303/322 ; Total Articles:37; JCI Quartile:Q4; JCI Percentile:6.06; Eigenfactor:0; Normalized Eigenfactor:0.082; Article Influence Score:0.107; JIF Percentile:5.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:44; % of Articles in Citable items:0.8409; Cited Half-Life:4.8; Citing Half-Life:7.9; % of OA Gold:0.9951; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLANDS, 2300
下一頁 »
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-4 21:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
返回頂部 返回版塊
眉山市| 福州市| 内丘县| 济源市| 银川市| 连州市| 屏山县| 海原县| 华坪县| 华池县| 延长县| 神农架林区| 高要市| 卫辉市| 青田县| 呼和浩特市| 寿阳县| 云南省| 望城县| 叶城县| 竹山县| 凉城县| 宝兴县| 平顶山市| 平安县| 德化县| 独山县| 井陉县| 乃东县| 栖霞市| 方山县| 兴安县| 民乐县| 马公市| 泰顺县| 东乡县| 郎溪县| 舒城县| 绥化市| 高邮市| 庆安县|